David Vanunu - Hod Assaf Chief Ltd
HOD Stock | ILS 5,057 13.00 0.26% |
Insider
David Vanunu is Chief Ltd of Hod Assaf Industries
Phone | 972 4 901 5000 |
Web | https://www.hodmetal.co.il |
Hod Assaf Management Efficiency
The company has return on total asset (ROA) of 0.0709 % which means that it generated a profit of $0.0709 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1904 %, meaning that it generated $0.1904 on every $100 dollars invested by stockholders. Hod Assaf's management efficiency ratios could be used to measure how well Hod Assaf manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Abbas Hussain | Teva Pharmaceutical Industries | 54 | |
Rami Myerson | Elbit Systems | N/A | |
Deborah Griffin | Teva Pharmaceutical Industries | N/A | |
Zvika Abramovich | Bezeq Israeli Telecommunication | N/A | |
Niv Polani | Bank Hapoalim | 55 | |
Eliav David | Bank Leumi Le Israel | N/A | |
Andrew Weil | Teva Pharmaceutical Industries | 52 | |
Avraham Ortal | Bank Leumi Le Israel | 56 | |
Amit Kurland | Bezeq Israeli Telecommunication | 52 | |
Ziv CPA | Bank Leumi Le Israel | 52 | |
Ronit SatchiFainaro | Teva Pharmaceutical Industries | 46 | |
Amir Weiss | Teva Pharmaceutical Industries | 46 | |
Eli Shani | Teva Pharmaceutical Industries | N/A | |
Shmulik Arbel | Bank Leumi Le Israel | 54 | |
Yaacov Kagan | Elbit Systems | N/A | |
Eyal BenHaim | Bank Leumi Le Israel | 52 | |
Kathleen Veit | Teva Pharmaceutical Industries | N/A | |
Haim Delmar | Elbit Systems | 49 | |
Amit Oberkovich | Bank Hapoalim | 59 | |
Avivit Klein | Bank Leumi Le Israel | 54 | |
Ilan Sigal | Bezeq Israeli Telecommunication | 48 |
Management Performance
Return On Equity | 0.19 | |||
Return On Asset | 0.0709 |
Hod Assaf Industries Leadership Team
Elected by the shareholders, the Hod Assaf's board of directors comprises two types of representatives: Hod Assaf inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hod. The board's role is to monitor Hod Assaf's management team and ensure that shareholders' interests are well served. Hod Assaf's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hod Assaf's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yifat Gabay, Accountant | ||
Doron Zilberberg, Chief SrmhRomania | ||
David Vanunu, Chief Ltd | ||
Ron Amir, Gen division | ||
Yossi Leomer, Ma Plant |
Hod Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hod Assaf a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.19 | |||
Return On Asset | 0.0709 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.07 % | |||
Current Valuation | 895.43 M | |||
Shares Outstanding | 12.29 M | |||
Shares Owned By Insiders | 88.19 % | |||
Price To Book | 0.82 X | |||
Price To Sales | 0.29 X | |||
Revenue | 1.74 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Hod Stock
Hod Assaf financial ratios help investors to determine whether Hod Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hod with respect to the benefits of owning Hod Assaf security.